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Objectives: Fentanyl iontophoretic transdermal system (ITS) is the first needle-
free, pre-programmed transdermal delivery system for patient-controlled analge-
sia (PCA) and management of acute post-operative pain (POP) in adult patients. 
Clinical practice requires comparisons to POP treatments in current practice such 
as epidurals, multimodal regimens (nerve blocks and intravenous opioids), long act-
ing analgesics, or intravenous PCA. This analysis compared the clinical safety and 
tolerability of fentanyl ITS relative to current POP strategies used following major 
hip and knee orthopedic surgeries. MethOds: A systematic literature review was 
conducted to identify all RCTs of fentanyl ITS and POP treatments after major hip 
and knee orthopedic surgeries. Searches in EMBASE, MEDLINE, and the Cochrane 
Central Register of Controlled Trials from 1990 to August 2014 were conducted; 
reference lists of included studies and unpublished study reports were searched. 
The odds-ratios for three safety outcomes, “discontinuation due to adverse events 
[AEs]”, “pruritus” and “respiratory depression” were estimated using fixed- and 
random-effects Bayesian Network Meta-Analysis (NMA) models. Results: Forty 
six RCTs were included in the NMA. The fixed-effects model for “discontinuation 
due to AEs” showed that fentanyl ITS is significantly better than IV PCA morphine 
(OR 0.35, 95% CrI 0.16, 0.70). In the fixed-effects model for “pruritus”, fentanyl ITS 
performed significantly better than IV PCA morphine (OR 0.42, 95% CrI 0.22, 0.78) 
and continuous epidural (OR 0.24, 95% CrI 0.06, 0.93). In the analysis for “respiratory 
depression”, fentanyl ITS was not statistically significantly different from all other 
POP treatments. cOnclusiOns: Fentanyl ITS was comparable with other current 
POP treatments employed to manage POP following major hip and knee surgery, 
offering a similar clinical safety and tolerability profile to current POP alternatives. 
Fentanyl ITS may be a suitable complement for multimodal therapeutic approaches 
or a potential replacement for certain regimens in terms of safety and tolerability.
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Objectives: Five recently published RCTs showed positive effects of mechanical 
thrombectomy for treating acute ischemic stroke patients. The objective of this 
study is to review the effect of methodological differences in these trials on their 
comparability and results. MethOds: This study critically examines the main char-
acteristics of the five RCTs including trial design, inclusion criteria, intervention 
methods and related time factors on the assessment of mechanical thrombec-
tomy trial results. Results: The multicenter trials MR CLEAN, ESCAPE, EXTEND-IA, 
SWIFT-PRIME and REVASCAT prospectively randomised patients to standard care 
(usually thrombolysis) alone or standard care plus mechanical thrombectomy. MR 
CLEAN was notably the only ‘pragmatic trial’. The number of patients randomised 
ranged from 70 to 500, with three studies stopping early due to efficacy. Two RCTs 
used intraarterial treatment where choice of therapy was left to a certain level 
of interventionists’ discretion, with retrievable stents recommended. Three RCTs 
focused on thrombectomy with a specific device, the Solitaire FR stent retriever. 
Inclusion criteria differed in terms of imaging modalities used, thrombus location, 
and time intervals for treatment ranging between 4.5-12 hours after symptom onset. 
Further variations concerned process times and measurement. In all studies, the 
outcome of modified Rankin Scale at 90 days favoured thrombectomy (adjusted odds 
ratios ranged from 1.67 to 3.1). Higher rates of functional independence in favour of 
thrombectomy were noted in all RCTs, improvements ranged from 32.6 vs 19% to 71 
vs 40%. MR CLEAN exclusively reported the safety variable “new ischemic stroke in 
a different vascular territory within 90 days” as 5.6 and 0.4% in the thrombectomy 
and control groups, respectively. cOnclusiOns: The results of five recent RCTs 
focusing on thrombectomy are highly promising but methodological heterogeneity 
of these studies affects the comparability of efficacy and safety results. Caution is 
therefore needed when drawing overall conclusions for HTA reporting.
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Objectives: Strokes are associated with high rates of morbidity and are the global 
second leading cause of death. Up to 40% of ischaemic strokes are cryptogenic. 
A network meta-analysis to compare the effectiveness of patent foramen ovale 
closure in patients with cryptogenic stroke or embolism. MethOds: A systematic 
literature search for randomized clinical trials for patent foramen ovale closure was 
undertaken for the databases Pubmed, Embase, Biosis, Google Scholar and Cochrane. 
Data was collected for the study type, methods, country and key findings. Extracted 
study data included study design, patient charatcertristcis and stroke related out-
comes. A bayesian random effects network meta-analysis model was developed 
Objectives: The aim of our study was to analyze the clinical pathway of the 
patients with breast tumor, who were screened by the mammographic breast 
screening program. MethOds: The data derive from the database of the National 
Health Insurance Fund Administration. The patients include all the women having 
“42400 mammography screening “code in the year of 2008. We followed these 
patients’ first appearances in the health care system. Diagnostic delay was called 
as the time difference between the date of the screening and the date of the 
first appearance in the outpatient care system, the treatment delay called as the 
time difference between the date of screening and the date of first appearance 
in the inpatient care system. Results: In 2008, 232.321 women participated in 
the organized mammography breast screening program in 44 institutions. The 
median value of the diagnostic delay was 47 days. Within diagnostic delay, there 
was a 30 days delay of definitive pathological diagnosis. Based upon the DRG 
codes the median value of the treatment delay was 70.75 days for surgical inter-
ventions and 191.75 days for radiotherapy. In comparison with the 2002 year data 
we found that the diagnostic delay was usually decreased with 10-20 days, while 
the median value of the treatment delays was increased on the average of 26-30 
days. In 2012 the same delays were about twice longer. cOnclusiOns: In com-
parison with the dates described by the international literature our national health 
care system works 1.5-2 times longer delays. The examination of the patients’ 
clinical pathways may allow of determining diagnostic and treatment delays of 
health care system. It would be necessary to optimize and reduce the clinical 
pathways with the participation of the all the professionals involving oncologic 
patients’ clinical pathway, and to determine the expected and achieved standard 
values.
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Objectives: In the differential diagnosis of a simple contact dermatitis (CD) and 
pressure ulcers (PU) in patients with urinary and fixed holds a special place visual 
assessment of skin. However, not all possess this skill, and telemedicine consulta-
tions are considered expensive. MethOds: The researcher evaluated the patient’s 
skin by questionnaire, and then spent photographic images of the skin in the 
standard points. Expert remotely evaluated the skin by photographs and then the 
diagnoses were compared. Calculated the cost of the methodology. Results: The 
expert noted no changes of the skin in 459 (86.3%) points at the bedside only 383 
(72%) points. According to the expert diagnosis was made in 29 (5.5%) points, 1-2 
tbsp. PU is set to 39 (7.3%) points 3-4 art. P - 5 (0.9%) points. Immediately patient 
diagnosed CD 53 set (10%) points 1-2 tbsp. PU - 88 (16.5%) points 3-4 tablespoons. 
PU - 8 (1.5%) points. Expert significantly less often seen in photographs erythema, 
cracks and peeling. According to the results of teleconsultation diagnosis pressure 
ulcers raised 2 times less frequently than directly from the patient. Almost 2 times 
less expert described contact dermatitis. The number of mismatches conclusions 
severe pressure ulcers with other changes of the skin is relatively low and difficult 
to interpret. The total costs of teleconsultation was 5 $ for 1 patient. cOnclusiOns: 
The use of teleconsultation allows for a relatively low cost to refine the differential 
diagnosis of CD and PU, which optimizes tactics of conducting patients, reduces 
the overall cost of patients.
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Objectives: Accurate estimation of blood loss is central to prompt diagnosis and 
management of post-partum hemorrhage(PPH), which remains a leading cause of 
maternal mortality in low-resource countries. In such settings, blood loss is often 
estimated visually and subjectively by attending health workers, due to inconsist-
ent availability of laboratory infrastructure. We evaluated the diagnostic accuracy 
of weighed blood loss(WBL) versus changes in peri-partum hemoglobin to detect 
PPH. MethOds: Data from this analysis were collected as part of a randomized 
controlled trial comparing oxytocin with misoprostol for PPH(NCT01866241). Two 
blood samples for complete blood count were drawn on admission and prior to 
hospital discharge or before blood transfusion. After delivery, blood was drained 
into a calibrated measuring jar and the subsequent weight differences of pre-
weighed sanitary towels added to estimate WBL(1g= 1mL).Sensitivity, specificity, 
negative and positive predictive values(PPVs) were calculated and receiver-oper-
ator curves fitted. Results: A total of 1,140 women were enrolled in the study, of 
whom 258(22.6%) developed PPH, defined as a hemoglobin drop > 10%, and 23.0% 
had WBL ≥ 500mL.WBL generally had a poor sensitivity for detection of PPH(< 75% 
for most volume-time combinations). In contrast, the specificity of the WBL was 
high with blood loss ≥ 500mL at 1h and ≥ 750mL at all-time points excluding PPH 
in over 97% of women. As such, WBL has promise as a diagnostic technique to 
identify PPH in higher-prevalence settings, where the high specificity corresponds 
to a high PPV(> 85%) when WBL exceeds 750mL. cOnclusiOns: WBL has poor 
sensitivity but high specificity for PPH versus laboratory-based methods of hem-
orrhage detection. These characteristics correspond to a high PPV in areas with 
high PPH prevalence. Although WBL is not useful for excluding PPH, this low-cost, 
simple and reproducible method seems promising as a reasonable alternative 
method to “rule-in” significant PPH in such settings where quantifiable red cell 
indices are unavailable.
